Riyadh - SPA
SFDA Approves Importing, Using Oxford-AstraZeneca COVID-19 Vaccine

Saudi Food and Drug Authority (SFDA) has approved importing and using the Oxford-AstraZeneca COVID-19 Vaccine.

The SFDA's approval was based on received data, which have been reviewed in all their details according to an accurate scientific method. Accordingly, health authorities in the Kingdom of Saudi Arabia will start procedures for using the vaccine in accordance with relevant standards and requirements. The SFDA will analyze samples from each incoming vaccine shipment before using it.

The SFDA pointed out that it is working according to a scientific mechanism to approve the use of vaccines, as it studies the safety, efficacy and quality of vaccines through experiments and clinical studies, and scientific data that show the quality of manufacture and product stability.

Related News